Analysis of the European Contract Research Outsourcing Markets

Opportunities in the Rapidly Changing Clinical Drug Development Outsourcing Market Across Europe

Regular Price: USD 4,950

Special Price USD 3,713

25% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,713

PAY BY INVOICE

Be the first to review this product

The scope of this research service is to provide an in-depth analysis of the contract research opportunities available in the European therapeutic market. It analyses the revenue potential, market dynamics, trends and competitive structure. The European Contract Research Outsourcing (CRO) revenues have been derived from the preclinical and clinical services offered by contract research organisations to pharmaceutical and biotechnology sponsors in conducting clinical trials. The markets analysed in this research service have been approached from a service provider’s point of view. The CRO market has been exclusively segmented based on stages of clinical trials, therapeutic services and geographies.

Table of Contents

Analysis of the European Contract Research Outsourcing Markets, Executive SummarySnapshot of the Contract Research Organisations MarketSummaryAnalysis of the European Contract Research Outsourcing Markets, Market OverviewOverview of the Contract Research Organisations MarketOverviewAnalysis of the European Contract Research Outsourcing Markets, External Challenges: Drivers and Restraints- Total MarketOverview of the Markert Drivers and RestraintsAnalysis of the Market Drivers and RestraintsAnalysis of the European Contract Research Outsourcing Markets, Forecasts and Trends - Total CRO Market Overview of the Revenue Forecasts and TrendsAnalysis of the Market Forecasts and TrendsAnalysis of the European Contract Research Outsourcing Markets, Market Share and Competitve Analysis - Total CRO MarketMarket Share and Competitive Analysis: Contract Research Organisations MarketAnalysis of the Market Share and Competitive AnalysisAnalysis of the European Contract Research Outsourcing Markets, Segment Analysis by Stages of Clinical Development Segmentation Based on Stages of Clinical DevelopmentAnalytical Laboratory Testing Preclinical TrialsPhase I TrialsPhase II TrialsPhase III TrialsOther StagesAnalysis of the European Contract Research Outsourcing Markets, Segment Analysis by TherapeuticsSegmentation Based on the Area of TherapyCardiovascular TherapeuticsCNS Disorders TherapeuticsEndocrine and Metabolic Disorders TherapeuticsOncology TherapeuticsInfectious Diseases TherapeuticsOther TherapeuticsAnalysis of the European Contract Research Outsourcing Markets, Segmentation by Geography Analysis by Geographic RegionsGermany BreakdownFrance BreakdownThe United Kingdom BreakdownSpain BreakdownItaly BreakdownAnalysis of the European Contract Research Outsourcing Markets, The Last WordConclusionThe Last WordLegal DisclaimerAnalysis of the European Contract Research Outsourcing Markets, AppendixSupport Data TablesMarket Engineering MethodologyDatabase of Key Industry ParticipantsDecision Support Database




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.